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Bile secretion by hepatocytes involves the movement of water from portal bloodstream into bile canaliculus in response to transient osmotic gradients generated by active solute transport (31) . Although evidence has been provided suggesting facilitation of osmotic water transport during canalicular bile secretion by apical AQP8 (17, 30) , no direct information is currently available regarding the possible water channel function of hepatocyte AQP9 and its potential relevance to primary bile formation in health and disease.
Extrahepatic cholestasis is an abnormal condition characterized by biliary obstruction leading to reduction of bile flow and impairment of various transport mechanisms in both basolateral and canalicular membranes of hepatocytes (25) . Dysregulation in the molecular expression of hepatocyte membrane transporters in obstructive cholestasis have been extensively investigated by using a model of bile duct ligation (BDL) in the rat. Interestingly, our recent work finding downregulated expression of hepatocyte AQP8 in BDL rats suggested pathophysiological relevance for liver AQPs in obstructive cholestasis (4) . Thus the main purpose of this study was to determine the effect of BDL on the basolateral membrane osmotic water permeability and expression and subcellular distribution of AQP9 in rat liver.
MATERIALS AND METHODS

Animals and treatment.
Adult male Wistar rats (250 -300 g; 3 mo old; Harlan) were maintained on a standard diet and water ad libitum and housed in a temperature-and humidity-controlled environment under a constant 12:12-h light-dark cycle. Under ether anesthesia, the common bile duct was double ligated and cut between the ligatures. Control animals underwent a sham operation that consisted of exposure, but not ligation, of the common bile duct. After 1, 3, and 7 days of ligation, the animals were euthanized and livers were harvested for evaluation. Each experimental (BDL) or control (sham) group consisted of three to five rats. Dysregulated bile flow was verified by assaying the serum alkaline phosphatase activity and total bilirubin level as previously described (4) . The protocol was conducted accord-ing to the Guiding Principles for the Care and Use of Laboratory Animals.
Semiquantitative RT-PCR. Livers were removed from euthanized rats and frozen in liquid nitrogen. Total RNA from livers of sham operated or BDL rats was isolated by the TRIzol reagent (Invitrogen, San Diego, CA) following the manufacturer's protocol. The samples of total RNA were submitted to semiquantitative RT-PCR as previously described (2) by using the rat AQP9 primers AQP9-start (5Ј-ATGCCTTCTGAGAAGGACGG-3Ј) and AQP9-stop (5Ј-CTA-CATGATGACACTGAGCT-3Ј), which lead to the amplification of a 885-bp fragment of DNA. RT-PCR reactions were normalized against the ␤-actin expression (2) .
Preparations of liver subcellular membrane fractions. Cholestatic and sham-operated livers were homogenized by 15 up-down strokes with a loose fitting Dounce homogenizer in four volumes of 0.3 M sucrose, containing 0.1 mM phenylmethylsulfonyl fluoride and 0.1 mM leupeptin (Sigma, St. Louis, MO). Total liver homogenates were subjected to low-speed centrifugation at 800 g for 10 min to obtain postnuclear supernatants and then subjected to centrifugation at 200,000 g for 60 min, yielding the total liver membrane fraction (10) . Fractions enriched in total plasma membranes, basolateral membranes, or intracellular microsomal membranes were prepared from liver homogenates by differential centrifugation on discontinuous sucrose gradients as previously described (4, 10, 17) . Proteins in plasma membrane fraction were assayed according to the method of Lowry (28) . Enrichment and purity of plasma membranes were comparable to those reported previously (4, 30, 32) .
Preparation of basolateral membrane vesicles and stopped-flow light scattering measurement of water and glycerol permeabilities.
The basolateral membrane vesicles were prepared as previously described (30) . The size of vesicles was determined with an N5 Submicron Particle Size Analyzer (Beckman Coulter, Palo Alto, CA) and by transmission electron microscopy. The time course of vesicle volume change was followed from changes in intensity of scattered light at the wavelength of 450 nm by using a Jasco FP-6200 (Jasco, Tokyo, Japan) stopped-flow reaction analyzer that has a 1.6-ms dead time and 99% mixing efficiency in Ͻ1 ms. Vesicle osmotic water permeability was measured by light scattering at 20°C as previously described (1) . Briefly, 35 l of a concentrated vesicle suspension was diluted into 2.5 ml of a hypotonic (220 mosM) isolation medium (124 mM mannitol, 70 mM sucrose, 20 mM Tris ⅐ HCl, 1 mM EDTA and 5 mM EGTA, pH 7.4). One of the syringes of the stopped-flow apparatus was filled with the specimen suspension, whereas the other was filled with the same buffer to which mannitol was added to reach a final osmolarity of 500 mosM to establish a hypertonic gradient (140 mosM) upon mixing. The final protein concentration after mixing was of 100 g/ml. Immediately, after application of a hypertonic gradient, water outflow occurs, and the vesicles shrink, causing an increase in scattered light intensity. The data were fitted to a single exponential function and the related rate constant (K i, s Ϫ1 ) of the water efflux out of the analyzed specimen was measured. The osmotic water permeability coefficient (P f), an index reflecting the osmotic water permeability of the vesicular membrane, was deduced from the K i as described (42) , using the equation:
where K i is the fitted exponential rate constant, V0 is the initial mean vesicle volume, A v is the mean vesicle surface, Vw is the molar volume of water, and ⌬C is the osmotic gradient. The medium osmolarity was verified by a vapor-pressure osmometer (Wescor, Logan, UT). For measurement of glycerol permeability, vesicles were subjected to a 150 mM inwardly directed gradient of glycerol as previously reported by Yang and coworkers (47) . Glycerol permeability (P gly; cm/s) was computed by using the equation:
where S/V is surface-to-volume ratio and is the exponential time constant fitted to the vesicle swelling phase of light scattering time course corresponding to glycerol entry.
Immunoblotting. Plasma membrane fractions were subjected to SDS-PAGE and transferred to polyvinyl difluoride membranes (NEN Life Science Products, Boston, MA). After blocking and washing, blots were incubated overnight at 4°C with rabbit affinity-purified antibodies against AQP9 (1 g/ml; Alpha Diagnostics International, San Antonio, TX) or for 2 h at room temperature (RT) with a 1:5,000 dilution of goat antibodies against Na ϩ -K ϩ -ATPase (CalbiochemNovabiochem, La Jolla, CA). The blots were washed and then incubated for 1 h at RT with corresponding horseradish peroxidaseconjugated secondary antibodies. Protein bands were detected by enhanced chemiluminescence detection system (ECL, Amersham, Little Chalfont, UK). Autoradiographs were obtained by exposing the membranes to Kodak XAR films, and the bands were quantified by densitometry using Gel-Pro32 software (Gel-Pro Analyzer, Media Cybernetics, Silver Spring, MD).
Immunohistochemistry. Cholestatic and sham-operated rats were euthanized after ether anesthesia and their livers were quickly removed, sliced, and fixed overnight by immersion with 4% paraformaldehyde. For the immunoperoxidase light microscopy, samples of liver were quickly processed to be included in a hydrophilic resin (Technovit 8100, Heraeus-Kulzer, Wehrheim, Germany) and processed as previously reported (1) . For the immunofluorescence experiments, after being washed the livers were incubated overnight in PBS with 30% sucrose added and were embedded in Optimal Cutting Temperature embedding medium (Bio-Optica, Milan, Italy). Frozen sections were cut to a thickness of 4 m. The sections were washed in PBS for 10 min and then blocked with PBS-gelatin 0.1% for 15 min at RT before being incubated with the rabbit affinity-purified antibodies against the rat AQP9 (3 g/ml) for 2 h at RT. Negative controls were performed by omitting the primary antibody. After three 5-min washes in PBS-gelatin 0.1%, the sections were incubated with FITCconjugated goat anti-rabbit secondary antibody (Molecular Probes, Eugene, OR) for 1 h at RT. The sections were again washed one time in PBS added with NaCl 2.7% followed by two 10-min washes in PBS. The coverslips were mounted by using a mounting medium consisting of glycerol 50%, Tris ⅐ HCl 0.2 M, pH 8.0 and n-propyl gallate 2.5%. The section's fluorescence intensity was quantified and displayed graphically via a Leica DMRXA photomicroscope equipped with a CCD camera (Princeton Instruments, New York, NY).
Immunogold electron microscopy. Samples of liver were fixed in a mixture of 3% paraformaldehyde and 1% glutaraldehyde in 0.1 M PBS, at pH 7.4, for 4 h at 4°C. Some specimens were postfixed in 1% OsO 4 in PBS for 30 min at 4°C. Fixed specimens were dehydrated in ethanol then embedded in Epon (Taab, Reading, UK). For immunoelectron microscopy, ultrathin sections of osmicated samples were oxidized with sodium metaperiodate to restore specific labeling. Both osmicated and nonosmicated sections were treated with 0.05 M glycine in PBS buffer for 15 min at RT. Grids were incubated for 30 min at RT with 1% BSA in PBS containing 0.2% gelatin (PBG) and then placed on a drop of AQP9 antibodies (10 g/ml of PBG) overnight at 4°C. The grids were then incubated in 1:10 10-nm gold-conjugated anti-rabbit IgG (Sigma) in PBG for 1 h at RT and lightly stained with uranyl acetate and lead citrate. Finally, the grids were observed with a Zeiss EM 109 electron microscope. Immunolabeling controls were performed as in immunofluorescence.
Statistical analysis. Experiments with each group of animals were performed at least in triplicate. Means Ϯ SE were calculated based on three to five independent preparations. Data were analyzed statistically by the Student's t-test. Results were considered statistically significant when P Ͻ 0.05.
RESULTS
Ligation of the common bile duct resulted in extrahepatic cholestasis, as indicated by the increased serum levels of total bilirubin and alkaline phosphatase. Levels of total serum bilirubin increased to 6.7 Ϯ 0.7 mg/dl (sham-operated rats, 0.6 Ϯ 0.2 mg/dl) and serum alkaline phosphatase to 1,093 Ϯ 184 U/l (sham-operated rats, 434 Ϯ 57 U/l) at day 7 after BDL.
Effect of BDL on AQP9 mRNA expression. Semiquantitative RT-PCR analysis was performed to study the effect of BDL on AQP9 mRNA expression. Compared with sham-operated controls, levels of AQP9 mRNA were unchanged on day 1 and 3 of BDL but slightly decreased (Ϫ35%) on day 7 BDL (Fig. 1,  A and B) . The AQP9 mRNA expression was normalized against that of the housekeeper gene ␤-actin (Fig. 1A) .
Effect of BDL on AQP9 protein expression and subcellular distribution. Immunoblotting with liver total, plasma, and intracellular membrane fractions was performed to evaluate the effect of BDL on AQP9 protein expression and subcellular localization. One-day BDL did not affect the plasma membrane expression of AQP9 whereas a 25% reduction was seen at day 3 of BDL. After 7 days of BDL, there was a remarkable reduction of basolateral membrane AQP9 (Ϫ85%) (Fig. 2, A and D) . The AQP9 protein expression was compared with that of the Na ϩ -K ϩ -adenosine triphosphatase (␣ 1 subunit) (Fig. 2, C and  D) , a plasma membrane protein remaining unaltered during BDL (11) . Of note, the immunolabeling of the intracellular membrane fraction increased steadily from day 1 BDL and became remarkable at day 7 BDL (ϩ115%), whereas the weak intracellular immunoreactivity to AQP9 did not change in the sham livers. Overall, the AQP9 immunoreactivity detected in the total liver membrane fraction from day 7 of BDL rats was reduced by 49% (P Ͻ 0.01) compared with the sham counterpart (Fig. 2, E and F) . This finding suggests that the basolateral membrane insertion of AQP9 in cholestatic hepatocytes is impaired and the overall liver AQP9 protein is considerably reduced after 7 days of BDL (Fig. 2, B and D) . BDL did not alter the yield of total membrane proteins (data not shown). The downregulation of basolateral AQP9 was not due to insulin, a hormone exerting a negative effect on the expression of liver AQP9 (23), since 7 days of BDL did not change the insulinemia levels of the BDL and sham rats (0.28 Ϯ 0.1 vs. 0.29 Ϯ 0.1 mU/l, respectively).
BDL reduces both the water and glycerol permeability of the hepatocyte basolateral membrane. Functional experiments of stopped-flow light scattering were performed to evaluate whether the BDL-induced downregulation of basolateral AQP9 caused a reduction in basolateral osmotic water permeability.
To do that, basolateral membrane vesicles prepared from livers of sham or 7-day BDL rats were subjected rapidly (1 ms) to a hypertonic osmotic gradient of 140 mosM and the resulting time course of vesicle shrinkage was followed from the change in scattered light. Consistent with the BDL-induced decrease of basolateral membrane AQP9 seen above and suggesting a role for AQP9 in the osmotic permeability of hepatocyte basolateral membrane, the osmotic water permeability coefficient (P f ) of the vesicles obtained from cholestatic livers was significantly lower than the one measured with the vesicles from control livers (68.3 Ϯ 9.5 and 112 Ϯ 7.2 m/s, respectively; P Ͻ 0.01) (Fig. 3, A and B) . No change in scattered light was seen when vesicles were mixed with isosmotic buffer, proving the absence of mixing artifact (Fig. 3B) .
To verify whether the BDL-induced downregulation of AQP9 was also accompanied by a reduction of the facilitated glycerol transport in hepatocyte basolateral plasma membrane, glycerol permeability was compared in basolateral membrane vesicles from livers of sham or BDL rats 7 days after surgery. Glycerol permeability was measured by light scattering following a 150 mM inwardly directed gradient of glycerol as previously described by Yang and coworkers (47) . Experiments were performed at 20°C. Fig. 4A shows representative light scattering data, with the slow decrease in scattered light intensity corresponding to glycerol influx into vesicles. Consistent with the osmotic water permeability studies there was significant reduction in basolateral P gly coefficient in the liver of the BDL vs. sham rats (9.23 Ϯ 1.5 and 14.6 Ϯ 2.6 10 Ϫ6 cm/s, respectively; P Ͻ 0.01) (Fig. 4B) .
Effect of BDL on the immunocytochemical distribution of AQP9 in rat hepatocytes. Immunofluorescence and immunoperoxidase analyses with serial liver sections were performed to analyze at a subcellular level the effect of BDL on the expression and subcellular distribution of AQP9. By immunofluorescence, and in line with previous reports (7, 34, 35) , livers from sham-operated rats showed AQP9 in the basolateral membrane of hepatocytes ( Fig. 5A; arrows) . No immunoreactivity was seen in the canalicular membrane ( Fig. 5A, inset; arrowhead). No labeling was observed in normal (no surgery) liver sections by omitting the primary antibody (Fig. 5B) . When compared with the corresponding basal conditions (day 0), the AQP9 immunofluorescent pattern remained unaltered in the liver of the sham-operated rats at 1, 3 and 7 days (Fig. 5, C , E, and G) whereas it changed markedly in the BDL liver at day 1 and thereafter ( Fig. 5, D, F, and H) . At day 1 of BDL ( Fig. 5D ), AQP9 was observed both over the basolateral membrane (inset; arrow) and within the intracellular compartment (double arrows). After 3 days of BDL (Fig. 5F ), the intracellular immunostaining increased (double arrows) whereas the basolateral membrane reactivity was reduced (inset; arrow). Suggesting mistrafficking of AQP9 in hepatocyte at 7-day BDL, the immunofluorescence was mostly restricted within the cytoplasmic compartment (Fig. 5D, double  arrow) . This pattern of distribution was confirmed by immunoperoxidase light microscopy (Fig. 6) .
The altered subcellular distribution of hepatocyte AQP9 in BDL rats was also analyzed at an ultrastructural level by immunogold electron microscopy (Fig. 7) . In line with the above immunocytochemical studies, cholestatic hepatocytes (day 7 of BDL) showed predominant immunoreactivity within the cytoplasmic compartment associated with weak staining at the basolateral membrane (Fig. 7B) . This pattern was significantly different from the one of the control hepatocytes where the gold particles were mostly located over the basolateral plasma membrane (Fig. 7A) .
DISCUSSION
Extrahepatic cholestasis is a pathological condition caused by rapidly developing (acute) or long-term (chronic) interruption in the excretion of bile (i.e., bile solutes and water) into bile canaliculus (6) . After showing impaired expression of canalicular AQP8 water channels in the liver of BDL rats (4), here we evaluated AQP9 as possible basolateral water channel contributing to bile flow dysfunction of cholestatic hepatocyte. The major finding is that extrahepatic obstruction causes strong reduction of both basolateral AQP9 and osmotic water permeability suggesting that basolateral AQP9 also functions as water channel and is pathophysiologically relevant to extrahepatic cholestasis.
There is experimental evidence indicating that rat hepatocyte basolateral osmotic water transport is AQP mediated (30) . Since no other water channels are found in the rat hepatocyte AQP9 immunofluorescence is seen over the basolateral membrane of hepatocytes (A, arrows) and no reactivity is noted in the canalicular membrane (A, inset; arrowhead). Such profile of immunoreactivity is maintained in the livers of 1-, 3-, and 7-day sham rats (C, E, and G, respectively). B: negative control. At day 1 of BDL (D), AQP9 immunoreactivity is seen both over the basolateral membrane (inset; arrow) and within the intracellular compartment (double arrows). At day 3 of BDL (F), whereas the intracellular staining of AQP9 is steadily present (double arrows), the basolateral membrane labeling appears reduced both as extension and intensity (inset; arrow). At 7 days of BDL (H), the plasma membrane staining is very weak (single arrow) whereas extensive clouds of immunoreactivity are seen within the cytoplasmic compartment (double arrows). cv, Centrolobular vein. basolateral membrane (see Ref. 37 for a review), it is reasonable to hypothesize that AQP9 facilitates the sinusoidal movement of water across the hepatocyte basolateral membrane. Bile secretion by hepatocytes requires the osmotically driven transcellular transport of water (i.e., across basolateral and canalicular plasma membrane domains); thus AQP9 is expected to mediate the sinusoidal water transport during the formation of bile.
Hepatocyte AQP9 is currently known for mediating the uptake of plasma glycerol deriving from adipose lipolysis during starvation (3, 23, 38) , a feature in line with our finding that the BDL-induced downregulation of liver AQP9 is also accompanied with a reduction in the P gly coefficient of the hepatocyte basolateral plasma membrane (Fig. 4) . Hepatocyte AQP9 would therefore act as water or glycerol channel, depending on the physiological condition. The water channel activity of AQP9 may be relevant to primary bile formation, a function that may explain the rapid shifts of hepatocyte volume characterizing the so-called hepatocellular hydration state, an efficient mechanism of short-term control of canalicular secretion (16) . The involvement of AQP9 in canalicular bile formation is also supported by the downregulation to which such AQP undergoes in the liver of BDL rat. A similar dysregulation characterizes the water channel at the canalicular side, AQP8 (4). The mechanisms involved in the defective basolateral AQP9 expression in extrahepatic cholestasis may be specific for this particular bile secretory disorder, since, as we recently reported, hepatocyte AQP9 appears unaffected in Fig. 6 . Effect of bile duct ligation on the immunohistochemical distribution of AQP9 in rat hepatocytes. A, C, E, and G: liver sections from sham-operated rats. At day 0, AQP9 immunolabeling (brown staining) is seen over the basolateral membrane of hepatocytes (A, arrows; inset). Such profile of immunoreactivity is maintained in the livers of 1-, 3-, and 7-day sham rats (C, E, and G, respectively). B: negative control (absence of AQP9 antibody). D: day 1 of BDL. Low AQP9 reactivity is seen over the basolateral membrane of hepatocyte (arrows). Labeling is observed over the intracellular compartment (double arrows). Areas within the hepatic acinus show hepatocytes in their way to be decomposed (red dashed circle). These areas are surrounded by hepatocytes with weak (or absent) AQP9 reactivity (asterisks). F: day 3 of BDL. The labeling of the sinusoidal membrane (arrows; inset) is reduced as to the basal condition whereas the intracellular reactivity is increasingly evident (double arrows; inset). Hepatocytes with no immunoreactivity are seen within the acinus (asterisks). H: day 7 of BDL. Intracellular AQP9 staining predominates in nearly all hepatocytes (double arrows). Mitotic hepatocytes with considerable intracellular staining are often observed within the acinus (red dashed square). Magnification ϫ500 (insets, ϫ1,000).
sepsis-associated cholestasis induced by lipopolysaccharides (26) and estrogen-induced hepatocellular cholestasis (5), two forms of intrahepatic cholestasis. The recent observation that AQP9 is downregulated at both mRNA and protein levels in the liver of neonatal (but not adult) rats treated with the synthetic estrogen diethylstilbestrol has been interpreted as due to the higher susceptibility to estrogen-induced changes characterizing newborn animals compared with their adult counterparts (45) .
The observation that the 85% decrease of basolateral membrane AQP9 is associated with a 40% decrease of the basolateral membrane osmotic water permeability is valuable information in the understanding of the mechanisms of bile formation and consistent with the moderate water conductance characterizing AQP9 (3, 30) . This suggests, as shown before (30) , that the lipid membrane pathway may provide a nonnegligible contribution to the overall water permeability of the hepatocyte basolateral membrane. A similar explanation was given to describe the canalicular membrane water permeability (5, 26, 30) . A 40% decrease of basolateral membrane osmotic water permeability may be sufficient to impair the efficient coupling between osmotic solutes and water transport during bile formation. This possibility is supported by our recent work showing that a 22% decrease of the canalicular membrane osmotic permeability is associated with a 58% decrease of canalicular bile flow (5) . As seen for apical AQP8 (4), the rate of primary bile secretion may be a factor influencing the expression and distribution of AQP9 in hepatocyte. It is therefore conceivable to hypothesize that basolateral AQP9 is reduced following the impairment of the transient osmotic gradient caused by the defective sinusoidal bile salt uptake characterizing extrahepatic cholestasis (11) . Since canalicular expression of AQP8, an aquaporin having a considerably higher water channel activity than AQP9, is decreased after BDL (4, 5) , it is objectively not obvious to independently establish the exact importance of liver AQP9 in extrahepatic cholestasis. This difficulty may also explain why no apparent bile formation defects were seen in AQP9 knockout mice (38) . Downregulation of AQP9 may be secondary to defective primary bile secretion in the light of a recent work showing normal plasma levels of alkaline phosphatase and cholesterol, two biochemical parameters of cholestasis, in AQP9-null mice (38) .
Our data suggest, as previously for canalicular AQP8 in BDL rats (4), a posttranslational mechanism (e.g., increased protein degradation as a consequence of subcellular misrouting) for basolateral AQP9 downregulation in obstructive cholestasis. Altered plasma membrane targeting is a frequent mechanism of dysregulation affecting diverse hepatocyte transporters in cholestasis, including the basolateral Na ϩ /bile acid cotransporter (9, 11, 40, 41) . However, a novelty of the physiological process of primary bile formation raising from this work is the fact that loss of AQP9 occurs in the context of other sinusoidal membrane proteins being targeted correctly and/or increasing in expression after BDL [i.e., the multidrug resistance-associated proteins 3, Mrp3 (44) ]. Similar to canalicular AQP8 (5, 26) and AQPs expressed in cells other than hepatocytes (27, 29, 39) , misrouted AQP9 may be targeted for proteolysis through the proteasome and/or lysosome system. In this scenario, a role for insulin, a hormone negatively regulating AQP9 at a gene level (3, 23) , can be ruled out since both insulinemia and AQP9 transcript levels of the BDL rats did not change significantly during cholestasis.
Under the cholestasis conditions, a large amount of biliary lipids including cholesterol, bile acids, phospholipids, and bilirubin would accumulate within the hepatocyte. Indeed, the complex changes of both liver metabolism and functions with cholestasis are partly dependent on retention of hydrophobic bile salts (i.e., tauro-and glicochenodeoxycholate, major bile salts in rat bile) and reduced hepatic detoxification capacity (19, 21) . In turn, this status might activate injuring pathways that might cause the decrease of antioxidant defenses including glutathione levels, stimulate glutathione efflux from hepatocytes (15) , and induce necrosis by activating the mitochondrial membrane permeability transition (14) . Of note, maintenance of intracellular glutathione levels is important also for the regulation of bile formation (13) . These factors worsen hepatic oxidative stress, decrease glutathione stores, and impair the detoxification defenses (22, 43) . Indeed, in a recent study, we could show that in the liver, ongoing cholestasis was associated with early oxidative changes (36) . Further investigation is needed to evaluate whether these factors influence the expression and distribution of AQP9 in hepatocytes as well.
Because impaired hepatic fatty acid metabolism has been shown in either long-(21) and short-term (24) extrahepatic cholestasis it is conceivable to think that dysfunctional expression of hepatic AQP9 induced by BDL may influence fatty acid metabolism in the liver. Although this was not the primary aim of our study we believe unlikely a direct involvement of AQP9 Fig. 7 . Ultrastructural localization of hepatocyte AQP9 in 7-day BDL rats by immunogold electron microscopy. A: hepatocyte of sham-operated rat liver. AQP9 immunogold labeling is seen at the microvilli of the basolateral plasma membrane (single arrows). Poorly appreciable staining is seen within the intracellular compartment (arrowheads). B: hepatocyte of BDL rat. Predominant immunolabeling is observed intracellularly (arrowheads) whereas minor staining is encountered at the basolateral membrane compartment (single arrow). mc, mitochondrion; bm, basolateral membrane; bars, 300 nm.
in trygliceride synthesis since 1) increased plasma triglyceride levels are found in rats with BDL, suggesting increased export of esterified fatty acids (20) , and 2) plasma levels of glycerol and triglycerides are markedly increased in AQP9-null mice (38) .
In conclusion, this work finds that hepatocyte basolateral AQP9 protein is downregulated in obstructive extrahepatic cholestasis. Such reduction is associated with a considerable decrease of the basolateral membrane osmotic water permeability. As expected, a decrease of the basolateral glycerol permeability is also observed. Besides serving as glycerol facilitator, hepatocyte AQP9 may also function as a water channel in bile formation and secretion. Because hepatic AQP8 and AQP9 are both downregulated following BDL it is conceivable to hypothesize that a defective expression of aquaporin water channels contributes to primary bile secretory dysfunction in the cholestatic liver. Of note, the identification of novel pharmacological approaches can be speculated, in which biliary epithelia are the primary target cell in patients with cholestatic diseases.
